A recent meta-analysis tested the efficacy of sublingual immunotherapy with grass pollen tablets in the treatment of patients with seasonal allergic rhinoconjuntivitis.
The FDA has approved new options for major depressive disorder, schizophrenia, and metastatic non-small cell lung cancer, that clinicians should be aware of.
Researchers examined the role that wheat, gluten, and fermentable oliogo-di-monosaccharides and polyols sensitivity may play in causing irritable bowel syndrome symptoms.